AI Article Synopsis

  • A specific genetic variation in the APOBEC3C enzyme, affecting a single amino acid (serine to isoleucine at position 188), is found in around 10% of African populations and significantly boosts the enzyme's ability to fight off HIV-1 and SIV.
  • The study observed that this variant, APOBEC3CS188I, can edit the hepatitis B virus (HBV) both in lab cultures and in infected individuals.
  • Utilizing next-generation sequencing, researchers discovered that this edited variant enhances activity in a specific DNA editing context (5'TpCpA to 5'TpTpA), marking a new understanding of the enzyme's function and potential implications for HBV and nuclear DNA.

Article Abstract

Single-nucleotide polymorphism in APOBEC3C (resulting in a serine to isoleucine in position 188) is present in approximately 10% of African populations and greatly enhances restriction against human immunodeficiency virus-1 and simian immunodeficiency virus by improving dimerization and DNA processivity of the enzyme. In this study, we demonstrated in culture and in infected patients that hepatitis B virus (HBV) could be edited by APOBEC3CS188I. Using next-generation sequencing, we demonstrated that APOBEC3CS188I led to enhanced editing activity in 5'TpCpA→5'TpTpA context. This constitutes a new hallmark of this enzyme, which could be used to determine its impact on HBV or nuclear DNA.

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiac003DOI Listing

Publication Analysis

Top Keywords

hepatitis virus
8
apobec3c s188i
4
s188i polymorphism
4
polymorphism enhances
4
enhances context-specific
4
context-specific editing
4
editing hepatitis
4
virus genome
4
genome single-nucleotide
4
single-nucleotide polymorphism
4

Similar Publications

We conducted a survey for domestic cat hepadnavirus, an analog of human hepatitis B virus, in the endangered felid species Iberian lynx. Results revealed specific antibodies in 32.3% of serum samples and DNA in 0.

View Article and Find Full Text PDF

Background And Aim: Data are limited regarding etiology-specific trends for delisting and re-compensation for liver disease improvement among liver transplant (LT) listed candidates in the US.

Methods And Results: A retrospective cohort (2002-2022) using UNOS database examined etiology-specific trends for delisting and re-compensation due to liver disease improvement among candidates listed for LT. Of 120,451 listings in adults, 34,444 (2002-08), 38,296 (2009-2015), 47,711 (2016-2022) were analyzed.

View Article and Find Full Text PDF

Background/objectives: As people with human immunodeficiency virus experience longer life expectancy, other causes of morbidity and mortality are being increasingly identified. The incidence of non-alcoholic fatty liver disease has recently been on the rise in Indonesia. People with human immunodeficiency virus on antiretroviral therapy are also at an increased risk of having non-alcoholic fatty liver disease.

View Article and Find Full Text PDF

Background: Recently, there has been increasing interest in the exploration of the association between the hepatitis E virus () infection and malignancies; however, epidemiological data for infection among women with a gynecological tumors (GT) are limited. Herein, we investigated the correlation between and GT in Chinese women.

Methods: We recruited 452 women diagnosed with a primary GT and 452 healthy volunteers to investigate the possible routes and risk factors for infection.

View Article and Find Full Text PDF

Hepatitis B virus (HBV) infection is a major public health burden. In HBV endemic regions, high prevalence is also correlated with the infections acquired in infancy through perinatal transmission or early childhood exposure to HBV, the so-called mother-to-child transmission (MTCT). Children who are infected with HBV at a young age are at higher risk of developing chronic HBV infection than those infected as adults, which may lead to worse clinical outcome.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!